Skip to main content
ZJAMP Group Co., Ltd. logo

ZJAMP Group Co., Ltd. — Investor Relations & Filings

Ticker · 002758 ISIN · CNE100002029 LEI · 3003009OKT32LB5C0T64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,563 across all filing types
Latest filing 2019-05-28 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002758

About ZJAMP Group Co., Ltd.

https://www.znjtgf.com

ZJAMP Group Co., Ltd. specializes in the comprehensive distribution and supply chain management of agricultural production materials. The company’s core operations encompass the procurement, storage, and sale of essential inputs, including chemical fertilizers such as urea, potash, and compound fertilizers, as well as pesticides, seeds, and agricultural machinery. Beyond product distribution, the organization provides integrated technical services, modern logistics solutions, and agricultural consultancy to enhance crop yields and farming efficiency. By leveraging an extensive network of distribution centers and service stations, the group facilitates the stable supply of high-quality agricultural resources. Its business model focuses on bridging the gap between manufacturers and end-users through efficient resource allocation and value-added services.

Recent filings

Filing Released Lang Actions
关于深圳证券交易所重组问询函回复的公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement from Zhejiang Huatong Pharmaceutical Co., Ltd. responding to an inquiry letter from the Shenzhen Stock Exchange regarding a major asset restructuring. It discusses the company's convertible bond issuance, the feasibility of the bond-funded projects, compliance with regulatory requirements, shareholder lock-up commitments, and detailed information about the transaction counterparties and shareholding structure. The content is focused on regulatory compliance, transaction details, and clarifications related to a major asset restructuring and related financing. It is not a full annual or interim financial report, nor is it a simple announcement of a report. It is a regulatory disclosure responding to an inquiry letter, providing detailed explanations and compliance confirmations. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2019-05-28 Chinese
关于深圳证券交易所重组问询函延期回复的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from Zhejiang Huatong Pharmaceutical Co., Ltd. regarding a delay in responding to an inquiry letter from the Shenzhen Stock Exchange about a restructuring matter. It states the company will complete the reply by a certain date and emphasizes compliance with disclosure obligations. The document is short (749 characters) and serves as an announcement about the status of a regulatory inquiry response, not a full report or detailed financial disclosure. It does not contain financial statements, audit information, or detailed management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2019-05-27 Chinese
关于披露重大资产重组预案后的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Zhejiang Huatong Pharmaceutical Co., Ltd. regarding the progress of a major asset restructuring plan. It mentions ongoing audit and evaluation work, the need for board and shareholder approvals, and regulatory approvals from the China Securities Regulatory Commission. The document references previous announcements about the suspension and resumption of trading due to the restructuring. It also states that progress updates will be published every 30 days until the shareholder meeting notice is issued. The document is relatively short (1687 characters) and serves as a progress update on a restructuring transaction rather than the actual restructuring proposal or detailed financial report. It does not contain financial statements or detailed analysis but is an update on the capital transaction process. Therefore, it fits best under Capital/Financing Update (CAP).
2019-05-19 Chinese
2018年度股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the 2018 Annual General Meeting (AGM) of Zhejiang Huatong Pharmaceutical Co., Ltd. It details the legality of the AGM's convening, the qualifications of attendees, the voting procedures, and the voting results. The document does not contain financial statements or management discussion but focuses on the legal compliance and validation of the AGM process and resolutions. This type of document is typically classified as Declaration of Voting Results & Voting Rights Announcements (DVA) because it officially reports the voting outcomes and related procedural confirmations from the AGM. The document length (5666 characters) and content confirm it is not merely an announcement of a report but a detailed legal opinion on the AGM proceedings and voting results. Therefore, the appropriate classification is DVA with high confidence.
2019-05-13 Chinese
2018年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled as a "2018 年度股东大会决议公告" which translates to "2018 Annual General Meeting Resolution Announcement." It details the resolutions passed at the shareholders' meeting, including voting results on various proposals such as the 2018 annual report, profit distribution plan, appointment of auditors, and amendments to the company charter. The document includes specifics on meeting attendance, voting methods, and legal opinions on the meeting's validity. It does not contain the full annual report or financial statements but rather the official results and decisions made at the AGM. Therefore, this document is an official announcement of voting results from the Annual General Meeting, fitting the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length (5232 characters) and content confirm it is not merely a brief notice but a detailed voting result announcement, not the full report itself.
2019-05-13 Chinese
关于子公司获得药品经营许可证和GSP证书的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of a pharmaceutical business license and a Good Supply Practice (GSP) certificate by a subsidiary. It is a regulatory announcement about operational certification, not a financial report, management change, or shareholder meeting material. The document is short (840 characters) and does not contain financial data or detailed report content. It fits best as a general regulatory announcement about compliance and certification.
2019-05-07 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.